Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Coffman

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
The Journal of Experimental Medicine|July 26, 2006
Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activationCristiana Guiducci, Gary Ott, Jean H Chan, et al.
Nucleic Acids Research|August 22, 2003
Novel chimeric immunomodulatory compounds containing short CpG oligodeoxyribonucleotides have differential activities in human cellsJason D Marshall, Edith M Hessel, Josh Gregorio, et al.
Blood|September 11, 2004
Combination immunotherapy with a CpG oligonucleotide (1018 ISS) and rituximab in patients with non-Hodgkin lymphoma: increased interferon-alpha/beta-inducible gene expression, without significant toxicityJonathan W Friedberg, Helen Kim, Mary McCauley, et al.
Immunity|March 1, 2011
Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center responseBaidong Hou, Philippe Saudan, Gary Ott, et al.
Clinical & Developmental Immunology|October 25, 2003
Second-hand smoke increases bronchial hyperreactivity and eosinophilia in a murine model of allergic aspergillosisBrian W P Seymour, Edward S Schelegle, Kent E Pinkerton, et al.
European Journal of Immunology|July 29, 2003
A minimal human immunostimulatory CpG motif that potently induces IFN-gamma and IFN-alpha productionKaren Fearon, Jason D Marshall, Christi Abbate, et al.
Genome Biology|June 7, 2002
Microarray profile of differentially expressed genes in a monkey model of allergic asthmaJun Zou, Simon Young, Feng Zhu, et al.
Nature Medicine|September 23, 2008
Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infectionsJudith N Mandl, Ashley P Barry, Thomas H Vanderford, et al.
Oncotarget|January 11, 2020
Low-dose metronomic cyclophosphamide complements the actions of an intratumoral C-class CpG TLR9 agonist to potentiate innate immunity and drive potent T cell-mediated anti-tumor responsesWeng In Leong, Rachel Y Ames, Jessica M Haverkamp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 27, 2015
A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in MonkeysMelissa A Kachura, Colin Hickle, Sariah A Kell, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
The Journal of Experimental Medicine|July 26, 2006
Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activationCristiana Guiducci, Gary Ott, Jean H Chan, et al.
Nucleic Acids Research|August 22, 2003
Novel chimeric immunomodulatory compounds containing short CpG oligodeoxyribonucleotides have differential activities in human cellsJason D Marshall, Edith M Hessel, Josh Gregorio, et al.
Blood|September 11, 2004
Combination immunotherapy with a CpG oligonucleotide (1018 ISS) and rituximab in patients with non-Hodgkin lymphoma: increased interferon-alpha/beta-inducible gene expression, without significant toxicityJonathan W Friedberg, Helen Kim, Mary McCauley, et al.
Immunity|March 1, 2011
Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center responseBaidong Hou, Philippe Saudan, Gary Ott, et al.
Clinical & Developmental Immunology|October 25, 2003
Second-hand smoke increases bronchial hyperreactivity and eosinophilia in a murine model of allergic aspergillosisBrian W P Seymour, Edward S Schelegle, Kent E Pinkerton, et al.
European Journal of Immunology|July 29, 2003
A minimal human immunostimulatory CpG motif that potently induces IFN-gamma and IFN-alpha productionKaren Fearon, Jason D Marshall, Christi Abbate, et al.
Genome Biology|June 7, 2002
Microarray profile of differentially expressed genes in a monkey model of allergic asthmaJun Zou, Simon Young, Feng Zhu, et al.
Nature Medicine|September 23, 2008
Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infectionsJudith N Mandl, Ashley P Barry, Thomas H Vanderford, et al.
Oncotarget|January 11, 2020
Low-dose metronomic cyclophosphamide complements the actions of an intratumoral C-class CpG TLR9 agonist to potentiate innate immunity and drive potent T cell-mediated anti-tumor responsesWeng In Leong, Rachel Y Ames, Jessica M Haverkamp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 27, 2015
A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in MonkeysMelissa A Kachura, Colin Hickle, Sariah A Kell, et al.
Pageof 7